JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 3, 2006; DOI: 10.1124/jpet.106.111773


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.111773v1
320/1/448    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, R.
Right arrow Articles by Swanson, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, R.
Right arrow Articles by Swanson, H.


Received for publication July 31, 2006.
Revised October 2, 2006.
Accepted for publication October 2, 2006.

LACK OF THE AHR LEADS TO IMPAIRED ACTIVATION OF AKT/PKB AND ENHANCED SENSITIVITY TO APOPTOSIS INDUCED VIA THE INTRINSIC PATHWAY

Ran Wu 1, Li Zhang 1, Martin Hoagland 1, Hollie Swanson 1*

1 University of Kentucky

* Address correspondence to: E-mail: hswan{at}uky.edu

Abstract

The aryl hydrocarbon receptor (AHR) is a ligand activated transcription factor that is best known for its role in mediating the toxicity of many environmental contaminants such as 2,3,7,8 tetrachlorodibenzo-p-dioxin. However, the endogenous role of AHR, especially with respect to the apoptotic process, is largely unknown and contradictory. In this report, we have utilized a mouse hepatoma cell line (Hepa1c1c7) and its AHR-deficient derivative (LA1) to examine the effect of differing AHR levels on apoptosis susceptibility, in particular, apoptosis regulated by the intrinsic pathway. Towards this end, the cells were subjected to UV irradiation, hydrogen peroxide and serum starvation. Analyses of a number of different endpoints of apoptosis revealed that the LA1 cells were more sensitive to these stresses than the wild-type cells indicating that the AHR plays a cytoprotective role in the face of stimuli that initiate the intrinsic apoptotic pathway. A direct role of the AHR in mediating this effect was confirmed using both pharmacological and molecular approaches. Further analyses imply that lack of the AHR leads to an impaired survival response mediated by PI3K-Akt/PKB and to a lesser degree, EGFR activation. These findings indicate that exploring the use of AHR antagonist as agents that enhance the pro-apoptotic actions of cancer therapies may be a valid approach.


Key words: AHR, Akt, Apoptosis, EGFR, UV, antagonist


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
C. F.A. Vogel, W. Li, E. Sciullo, J. Newman, B. Hammock, J. R. Reader, J. Tuscano, and F. Matsumura
Pathogenesis of Aryl Hydrocarbon Receptor-Mediated Development of Lymphoma Is Associated with Increased Cyclooxygenase-2 Expression
Am. J. Pathol., November 1, 2007; 171(5): 1538 - 1548.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.